Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Chemotherapy and Trastuzumab for HER2-Positive Breast Cancer
NCT00464646Phase 2Completed
- Sponsor
- NSABP Foundation
- Start
- May 2007
- Primary completion
- Dec 2009
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of bevacizumab in breast cancer, sponsored by NSABP Foundation. Started May 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00464646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00464646.